Inventor · Berlin, DE

Carsten Möller

12Patents
2h-index
9Co-inventors
39Inventor score

Filing activity: Jul 7, 2010 → Apr 2, 2018

Most-cited inventions

PatentTitleAreaCited byStatus
US8278469B2 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases Chemistry; Metallurgy 4 Active
US9085603B2 Progesterone receptor antagonists Human Necessities 2 Active
US9717739B2 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases Chemistry; Metallurgy 2 Active
US10155004B2 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases Chemistry; Metallurgy 2 Active
US9109004B2 Progesterone receptor antagonists Human Necessities 1 Active
US10485808B2 Selective progesterone receptor modulators (SPRM) and stabilized estrogen level in patient Chemistry; Metallurgy 0 Active
US9096640B2 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-methylene oxyalkylene aryl derivatives, process for preparation thereof, and use thereof for treatment of diseases Human Necessities 0 Active
US9096639B2 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseases Human Necessities 0 Active
US9206219B2 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseases Chemistry; Metallurgy 0 Active
US9102701B2 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-ethynylphenyl derivatives, methods for the production thereof and use thereof for treating diseases Chemistry; Metallurgy 0 Active
US9156877B2 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzylidene derivatives, methods for the production thereof and use thereof for treating diseases Chemistry; Metallurgy 0 Active
US8969328B2 Progesterone receptor antagonists General 0 Revoked

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.